Aprameya Engineering Ltd

Aprameya Engineering Ltd

₹ 63.0 2.11%
26 Sep - close price
About

Incorporated in September 2003, Aprameya Engineering Limited specializes in installing and maintaining Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatres, and prefabricated structure wards in hospitals and medical care centers.[1]

Key Points

Business Segments[1]
A) Establishing healthcare infrastructure within hospitals and medical care centers.
B) Dealing in high-value medical equipment

  • Market Cap 120 Cr.
  • Current Price 63.0
  • High / Low 83.0 / 58.0
  • Stock P/E 34.6
  • Book Value
  • Dividend Yield 0.00 %
  • ROCE 11.8 %
  • ROE 16.0 %
  • Face Value 10.0

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 33.8%

Cons

  • Company might be capitalizing the interest cost
  • Company has high debtors of 325 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
12.23 25.93 35.00 78.12 65.16
10.64 23.52 24.95 68.67 58.81
Operating Profit 1.59 2.41 10.05 9.45 6.35
OPM % 13.00% 9.29% 28.71% 12.10% 9.75%
0.09 0.08 0.04 0.21 0.46
Interest 0.90 0.87 0.14 2.08 2.11
Depreciation 0.07 0.09 0.02 0.10 0.11
Profit before tax 0.71 1.53 9.93 7.48 4.59
Tax % 8.45% 43.79% 24.87% 28.21% 24.84%
0.65 0.86 7.46 5.37 3.46
EPS in Rs 10.66 3.84 2.47
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 36%
TTM: -17%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 59%
TTM: -36%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 34%
Last Year: 16%

Balance Sheet

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 3.74 4.34 7.00 14.00 14.00
Reserves 0.00 0.00 7.45 5.92 9.37
4.03 1.48 13.69 28.74 42.05
6.21 5.09 20.49 13.23 10.19
Total Liabilities 13.98 10.91 48.63 61.89 75.61
0.69 0.63 1.54 1.46 1.39
CWIP 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00
13.29 10.28 47.09 60.43 74.22
Total Assets 13.98 10.91 48.63 61.89 75.61

Cash Flows

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0.06 3.58 10.41 -13.49 -9.98
-0.57 0.03 -0.24 -1.83 -1.00
0.54 -3.67 -7.69 13.04 11.11
Net Cash Flow 0.04 -0.06 2.48 -2.28 0.14

Ratios

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 182.35 57.99 278.23 195.30 325.23
Inventory Days 245.38 121.90 454.87 375.97 73.78
Days Payable 268.89 146.76 1,099.89 414.62 145.83
Cash Conversion Cycle 158.84 33.13 -366.78 156.66 253.19
Working Capital Days 159.97 49.55 203.67 194.79 319.12
ROCE % 35.32% 59.31% 24.90% 11.75%

Shareholding Pattern

Numbers in percentages

4 Recently

Shareholding pattern is currently not available for this company.

Documents